VAV2 Brings Spanking New Life To A Old Matter: Defacto Traditional

?6D). Quantitative analysis.? The number of GLP-1R-IR neurons/slice in the myenteric plexus of duodenum and proximal colon, was 14.3?��?1.4 http://www.selleckchem.com/GSK-3.html and 16.1?��?1.2, respectively. The number of nNOS-IR neurons/slice in the myenteric plexus of duodenum and proximal colon, was 18.1?��?2.0 and 39.9?��?1.8, respectively. Among the GLP-1R-IR neurons, 27.22?��?3.14% in the duodenum and 79.67?��?4.5% in the colon, co-expressed nNOS-IR. Among the nNOS-IR neurons, 22.6?��?1.4% in the duodenum and 33.4?��?4.3% in the colon, co-expressed GLP-1R. The number of GLP-1R neurons that co-expressed ChAT-IR was http://www.selleckchem.com/screening/tyrosine-kinase-inhibitor-library.html effect on the small and large intestinal motility, independently by the neural extrinsic control. Furthermore, by immunohistochemistry, we presently show that GLP-1R is expressed in enteric neurons, in both duodenum and colon, and that some of these neurons co-expressed nNOS or ChAT. Taken together, immunohistochemical and functional data suggest that GLP-1 is able to modulate negatively the excitatory cholinergic neurotransmission in mouse duodenal and proximal colonic circular muscle, by acting on specific GLP-1R. This inhibitory effect seems to be mediated by a nitrergic pathway. In addition to its principal effect as potent incretin,3 GLP-1 can exert other actions in gastrointestinal tract, such as decrease in the rate of gastric emptying and reduction of gut motility, in a number of species including man, pigs, rats http://en.wikipedia.org/wiki/VAV2 and mice.4,8,9,11,13,14,16,26,27 However, the involvement of GLP-1 in the regulation of the motility of the gastrointestinal tract has been mainly supported by experiments conducted in in vivo conditions and multiple findings suggest that GLP-1 effects on motor function of the gastrointestinal tract are exerted through the interactions with centers in the brain or afferent neural pathways.11,17�C19,26�C30 Indeed, Giralt and Vergara,9 reported that the inhibitory effect of GLP-1 on rat upper gut motility was mediated via adrenergic pathways, thus also claiming a role for sympathetic pathways. Our results provide evidence that there are peripheral sites of action of GLP-1 at the level of the enteric nervous system. This conclusion appears in contrast with a previous study demonstrating that in rats GLP-1 does not affect spontaneous contractility or the evoked responses in isolated muscular strips, leading to the conclusion that the peptide does not modulate intestinal motility through a peripheral action.30 A likely explanation for the discrepancy between the previous observations and our results is the muscle layer used for the study. In our experiments, the GLP-1 effect was observed only on the electrically evoked responses of the circular muscle, whereas Tolessa and coll.